Following Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines, the patient was diagnosed with membranous nephropathy based on anti-PLA2R antibody levels [3]. Chest CT was negative for malignancy that could explain his membranous nephropathy. This evidence concerns the gene PLA2R1 and membranous glomerulonephritis.